“I was keen to go on a clinical trial. I wanted to try new cancer treatments and hopefully help future generations.”
A study looking at the management of breast cancer that has come back in the same breast or nearby areas (MARECA)
Cancer type:
Breast cancer
Status:
Open
Phase:
Other
This study is looking at the tests and treatment for people whose breast cancer has come back in the same breast or nearby area.
It is for people whose breast cancer has come back in the same breast, chest wall or nearby 
. This is locoregional breast cancer .
The aim is to make recommendations for the best care and treatment of people with this type of breast cancer recurrence.
Who can enter
The following bullet points are a summary of the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you.
Who can take part
You may be able to join this study if all of the following apply. You:
- have had treatment for invasive breast cancer or ductal carcinoma in situ (DCIS) with the aim to cure
- have within the past 6 months been diagnosed with breast cancer (invasive breast cancer or DCIS) in the same breast or chest wall and or nearby lymph nodes
- had surgery to remove the original cancer at least 3 months ago
- are at least 18 years old
Who can’t take part
You cannot join this study if any of these apply.
- Your original breast cancer had spread to another part of the body (secondary breast cancer).
- You had cancer diagnosed in 1 breast. And you now have cancer diagnosed in the other breast.
- You have secondary breast cancer. But there is no cancer in the breast, chest wall or lymph nodes.
- You have a rare cancer of the lining of the blood vessels or lymph vessels (angiosarcoma).
- You have another type of cancer and didn’t have treatment with the aim to cure.
- You had surgery to the breast for another type of breast condition that wasn’t cancer or for a soft tissue
sarcoma of the breast. Or you haven’t had surgery for a primary breast cancer in the same breast.
Trial design
The study team need up to 500 people to take part.
A member of your health care team will look at your medical records for the following information:
- the date of diagnosis of the cancer coming back in the same area
- general details about your medical history
- any tests, scans, or treatments you had for the original breast cancer and the breast cancer that has come back
They will continue to look at your medical records for up to 5 years after your diagnosis.
Tissue sub study
The team ask for your permission to look at tissue samples () from:
- when you were first diagnosed
- when your cancer came back
They plan to use these for future research into breast cancer.
You don’t have to agree to this if you don’t want to. You can still take part in the main study.
Hospital visits
There are no extra hospital visits for this study.
Side effects
There are no side effects if you take part in this study.
Location
Aberdeen
Basingstoke
Bodelwyddan
Bradford
Bristol
Chester
Chesterfield
Cottingham
Doncaster
Dundee
Exeter
Huddersfield
Keighley
Leeds
Leicester
Liverpool
Llanelli
London
Manchester
Milton Keynes
North Shields
Norwich
Perth
Poole
Redhill
Stirling
Stockton-on-Tees
Wakefield
Watford
Yeovil
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Chief Investigator
Mr Baek Kim
Supported by
Association of Breast Surgery (ABS)
Leeds Teaching Hospitals NHS Trust
Leeds Hospitals Charity
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
Last review date
CRUK internal database number:
17961
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Harriet wanted to try new treatments
